Pd-Catalyzed Oligocyclizations of 2-Bromoalk-1-ene-diynes
3
2.5ϫ20 cm, PE/Et2O, 4:1) to give 202 mg (61%) of 35a as a color-
1.92 (m, 3 H, 11,14-H), 2.10 (m, 1 H, 14-H), 2.56 (t, J = 10 Hz, 2
less oil. R (PE/Et O, 1:1) = 0.35. IR (film): ν = 2940, 1730 (C=O), H, 4-H), 2.58–2.74 (m, 2 H, 13-H), 2.74–2.88 (m, 3 H, 6,12-H),
˜
f
2
1580 (C=C), 1440, 1375, 1080, 1020, 920, 870, 790 cm–1. H NMR
2.96 (dd, 2J = 4, 3J = 15 Hz, 1 H, 6-H), 4.08 (m, 1 H, 5-H), 6.84 (s,
1 H, 8-H), 7.25–7.40 (m, 5 H, Ph-H) ppm. 13C NMR (150.82 MHz,
1
(250 MHz, CDCl3): δ = 1.22 (m, 6 H, OCH2CH3), 1.50–1.85 (m, 3
H, 11, 12-H), 2.10–2.27 (m, 1 H, 12-H), 2.70–2.90 (m, 1 H, 10-H), CDCl3, APT): δ = –4.62 [+, Si(CH3)2], –4.59 [+, Si(CH3)2], 18.30
3.10–3.25 (dt, 3J = 3.9, 2J = 18.1 Hz, 1 H, 10-H), 3.42 (s, 3 H, [–, C(CH3)3], 22.90 (–, C-3), 23.15 (–, C-11), 25.87 (–, C-12), 25.95
OCH3), 3.43–3.62 (m, 4 H, 3,5-H), 3.81 (s, 3 H, COOCH3), 4.12– [+, 3 C(CH3)3], 27.02 (–, C-13), 28.83 (–, C-4), 32.60 (–, C-14),
3
4.25 (m, 4 H, 2 OCH2CH3), 4.28 (t, J = 3.6 Hz, 1 H, 13-H), 7.64
39.55 (–, C-6), 68.13 (+, C-5), 126.53 (+, Ph-C), 127.91 (+, Ph-C),
128.12 (+, Ph-C), 128.44 (+, Ph-C), 128.49 (+, Ph-C), 128.52 (+,
(s, 1 H, 7-H) ppm. 13C NMR (62.9 MHz, CDCl3, DEPT): δ = 13.9
(+, OCH2CH3), 17.6 (–, C-11), 25.5 (–, C-12), 27.9 (–, C-10), 39.4 Ph-C), 128.73 (+, Ph-C), 129.27 (+, C-8), 132.22 (–, C-1), 132.37
(–, C-3), 40.0 (–, C-5), 51.5 (+, OCH3), 55.8 (+, COOCH3), 60.2 (–, C-2), 133.53 (–, C-7), 133.66 (+, Ph-C), 133.78 (+, Ph-C), 135.22
(Cquat, C-4), 61.6 (+, OCH2CH3), 74.3 (+, C-13), 125.6 (+, C-7), (–, C-10), 139.95 (–, Ph-C), 142.06 (–, C-9) ppm. MS (DCI, NH3):
129.0 (Cquat, C-8), 133.3 (Cquat, C-1), 137.5 (Cquat, C-9*), 138.2 m/z (%) = 410 (100) [M + NH4+], 495 (26) [(M – CH3) + NH4+],
(Cquat, C-6*), 145.3 (Cquat, C-2), 168.1 (Cquat, COOCH3), 171.1 352 (7) [M + H – C(CH3)3 + NH4+], 296 (12) [(M – tBuMe2Si) +
(Cquat, COOCH2CH3), 171.6 (Cquat, COOCH2CH3) ppm. MS (EI, NH4+], 279 (16) [M – H – tBuMe2SiO + NH4+], 263 (27).
70 eV): m/z (%) = 404 (0.2) [M+], 388 (1), 373 (4) [M+ – OCH3], C26H36OSi (392.6): calcd. C 79.53, H 9.24; found C 79.41, H 9.08.
299 (28), 167 (13), 165 (12), 140 (26), 112 (11), 110 (14), 91 (20),
45 (24), 44 (100). HRMS: calcd. for C22H28O7 404.183506 (correct
mass).
Trimethyl Tetracyclo[8.4.0.01,3.04,9]tetradeca-4,9-diene-3,6,6-tricarb-
oxylate (38): Following GP method A, palladium acetate (150 mg,
0.66 mmol) was added at 60 °C to a degassed mixture of tri-
Dimethyl 9-[tert-Butyl(dimethyl)silyl]tricyclo[8.4.0.02,7]tetradeca-
phenylphosphane (430 mg, 1.64 mmol), of potassium carbonate
1,7,9-triene-5,5-dicarboxylate (36): According to GP method A, di-
(2.72 g, 19.7 mmol), trimethyl 13-bromo-13-tetradecene-1,7-diyne-
methyl 2-bromo-14-(tert-butyldimethylsilyl)-1-tetradecen-7,13-di-
1,11,11-tricarboxylate (16) (2.9 g, 6.59 mmol) and acetonitrile
yne-4,4-dicarboxylate (22) (249 mg, 0.50 mmol) was added to a
(100 mL). After stirring the reaction mixture at 60 °C for 20 h and
mixture of palladium acetate (11 mg, 0.05 mmol, 10 mol-%), tri-
work-up as described in the GP, the residue was purified by column
phenylphosphane (33 mg, 0.13 mmol, 25 mol-%) and potassium
chromatography (60 g of silica gel, column 2 ϫ30 cm, pentane/
carbonate (207 mg, 1.5 mmol, 3 equiv.) in acetonitrile (5 mL). After
Et2O, 4:1) to afford 1.3 g (54%) of 38 as an orange oil. Rf (pentane/
heating the reaction mixture at 60 °C for 20 h and work-up as de-
Et O, 4:1) = 0.17. IR (film): ν = 2996, 2954, 2855, 1755, 1715, 1433,
˜
2
scribed in the GP, the resulting residue was purified by column
chromatography (20 g of flash silica gel, column 2ϫ35 cm, hexane/
Et2O, 10:1) to give 163 mg (79%) of 36 as a colorless oil. Rf (PE/
1302, 1226, 1197, 1154, 1076, 1062, 851, 833, 735, 702 cm–1. 1H
NMR (250 MHz, CDCl3): δ = 1.07 (d, 2J = 2.9 Hz, 1 H, 2-H), 1.24
2
3
(m, 1 H, 12-H), 1.46–1.56 (m, 1 H, 12-H), 1.68 (dt, J = 2.8, J =
15 Hz, 1 H, 14-H), 1.8–1.89 (m, 2 H, 11, 14-H), 1.95 (d, 2J =
3.0 Hz, 1 H, 2-H), 2.00–2.37 (m, 4 H, 7,8,13-H), 2.40–2.61 (m, 3
H, 8, 11, 13-H), 3.70 (s, 3 H, COOCH3), 3.72 (s, 3 H, COOCH3),
3.75 (s, 3 H, COOCH3), 6.09 (s, 1 H, 5-H) ppm. 13C NMR
(62.9 MHz, CDCl3, DEPT): δ = 19.15 (–, C-8), 24.82 (–, C-12),
24.93 (–, C-11), 25.36 (–, C-13), 27.98 (–, C-14), 28.70 (–, C-7),
36.65 (Cquat, C-3), 39.29 (–, C-2), 45.88 (Cquat, C-1), 51.80 (+, CO-
OCH3), 52.68 (+, COOCH3), 52.82 (+, COOCH3), 55.28 (Cquat, C-
6), 115.88 (+, C-5), 126.03 (Cquat, C-9), 143.53 (Cquat, C-4), 144.75
(Cquat, C-10), 170.96 (Cquat, COOCH3), 171.35 (Cquat, COOCH3),
171.72 (Cquat, COOCH3) ppm. MS (EI, 70 eV): m/z (%) = 360 (10)
[M+], 328 (24) [M+ – CH3OH], 301 (30) [M+ – COOCH3], 269 (46)
[M+ – CH3OH – COOCH3], 241 (39), 209 (20), 159 (30), 115 (72),
74 (79), 59 (100), 45 (64), 43 (27). C20H24O6(360.4): calcd. C 66.65,
H 6.43; found C 66.76, H 6.43.
Et O, 10:1) = 0.15. IR (film): ν = 2978, 2868, 1741 (C=O), 1638,
˜
2
1444, 1383, 1351, 1277, 1044, 935, 846 cm–1. HNMR (250 MHz,
1
CDCl3): δ = 0.50 [m, 6 H, Si(CH3)2], 1.07 [s, 9 H, C(CH3)3], 1.95
(m, 4 H, 12, 13-H), 2.53 (t, 3J = 6.6 Hz, 2 H, 4-H), 2.74 (t, 3J =
3
3
6.0 Hz, 2 H, 11-H), 2.83 (t, J = 6.6 Hz, 2 H, 3-H), 3.00 (t, J =
6.0 Hz, 2 H, 14-H), 3.47 (s, 2 H, 6-H), 3.91 (s, 6 H, OCH3), 7.08
(s, 1 H, 8-H) ppm. 13C NMR (62.9 MHz, CDCl3, DEPT): δ = –2.61
[+, 2 Si(CH3)2], 17.97 [Cquat, C(CH3)3], 22.85 (–, C-12*), 23.00 (–,
C-13*), 23.37 (–, C-3), 26.73 (–, C-11), 27.00 [+, 3 C(CH3)3], 28.21
(–, C-4), 32.08 (–, C-14), 35.14 (–, C-6), 52.64 (+, 2 OCH3), 53.10
(Cquat, C-5), 129.07 (Cquat), 133.62 (Cquat), 133.94 (Cquat), 134.31
(Cquat), 134.47 (+, C-8), 141.13 (Cquat), 171.81 (Cquat, 2 C=O) ppm.
MS (DCI, NH3): m/z (%) = 850 (17) [2 M + NH4+], 434 (100) [M
+ NH4+]. C24H36O4Si (416.6): calcd. C 69.16, H 8.71; found C
69.51, H 8.97.
5-(tert-Butyldimethylsilyloxy)-9-phenyltricyclo[8.4.0.02,7]tetradeca-
1,7,9-triene (37): Following GP method B, palladium acetate
(9.48 mg, 0.042 mmol) was added at 80 °C to a degassed mixture of
triphenylphosphane (28 mg, 0.10 mmol), sodium formate (34.4 mg,
0.50 mmol), 1-[13Ј-bromo-11Ј-(tert-butyldimethylsilyloxy)-13Ј-
tetradecene-1Ј,7Ј-diynyl]benzene (29) (200 mg, 0.42 mmol) and
DMF (5 mL). After stirring at 80 °C for 5 h, the reaction mixture
was poured into water (30 mL), and the aqueous mixture was ex-
tracted with diethyl ether (3ϫ20 mL). The combined ether layers
were dried (MgSO4), concentrated, and the residue was purified
by thick-layer chromatography using 20ϫ20 cm plates coated with
silica gel, type 60 PF254 containing CaSO4, eluting with pentane/
dichloromethane, 2:1. The third fraction from the top of the plates
afforded 25 mg (15%) of 37 as a yellow oil. Rf (pentane/dichloro-
Methyl 13-(tert-Butyldimethylsilyloxy)tetracyclo[8.4.0.01,3.04,9]-
tetradeca-4,9-diene-3-carboxylate (39): Following GP method A,
palladium acetate (9.8 mg, 0.050 mmol) was added at 60 °C to a
degassed mixture of triphenylphosphane (29 mg, 0.11 mmol), po-
tassium carbonate (182.6 mg, 1.3 mmol), methyl-14-bromo-12-
(tert-butyldimethylsilyloxy)-14-pentadecene-2,8-diynoate (27)
(200 mg, 0.44 mmol) and acetonitrile (5 mL). After heating the
mixture at 60 °C for 18 h and work-up as described in the GP, the
residue was purified by thick-layer chromatography using
20ϫ20 cm plates coated with silica gel, type 60 PF254 containing
CaSO4. The plates were developed twice, first eluting with pentane/
dichloromethane, 2:1, then with pentane/Et2O, 10:1. The first frac-
tion from the top of the plates afforded 32 mg (19%) of 2:1 of a
mixture of diastereomers of 39 as a colorless oil. Rf (pentane/Et2O,
methane, 2:1) = 0.55. IR (film): ν = 3057, 2927, 2856, 1462, 1251,
˜
1095, 882, 773 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.12 [s, 6
H, Si(CH3)2], 0.94 [s, 9 H, C(CH3)3], 1.60–1.72 (m, 2 H, 3-H), 1.76–
5:1) = 0.12. IR (film): ν = 2957, 2854, 2240, 1734, 1437, 1255, 1202,
˜
835, 777, 736 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.04 [s, 6 H,
Eur. J. Org. Chem. 2008, 6152–6167
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
6165